SIBIONICS et PharmaSens explorent de nouvelles perspectives pour l'administration automatisée d'insuline lors du congrès de l'EASD 2026

ConferenceNeutral

AI Analysis

Summary

SiBionics and PharmaSens presented their automated insulin administration initiative at the 2026 EASD congress, focusing on connecting continuous monitoring with future diabetes management approaches.

Importance:3/10

Sentiment:

0.00

diabetesinsulin deliveryautomated administrationcontinuous monitoringEASD 2026

Read the original article

Published by PR Newswire Clinical Trials on October 5, 2026 12:47 AM

Read Original